The Prognostic Value of HRAS mRNA Expression in Cutaneous Melanoma

Table 1

Clinicopathological and demographic characteristics of patients with cutaneous melanoma (TCGA, Provisional).

Characteristics	Cases number	Percentage (%)
Age
≤58	227	50.2
>58	225	49.8
Gender
Male	280	61.9
Female	172	38.1
AJCC stage
Stage I	75	16.6
Stage II	139	30.8
Stage III	167	36.9
Stage IV	21	4.6
Unknown	50	11.1
Tumor thickness (mm)
≤1.00	57	12.6
1.01~2.00	77	17.0
2.01~4.00	68	15.0
>4.00	146	32.3
Unknown	104	23.0
Ulceration
Absent	142	31.4
Present	163	36.1
Unknown	147	32.5
Overall survival
Living	236	52.2
Deceased	216	47.8